<?xml version="1.0" encoding="UTF-8"?>
<ref id="B49">
 <label>49.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Watanabe</surname>
    <given-names>M</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Hirano</surname>
    <given-names>A</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Stenglein</surname>
    <given-names>S</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Nelson</surname>
    <given-names>J</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Thomas</surname>
    <given-names>G</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Wong</surname>
    <given-names>TC</given-names>
   </name>
  </person-group>
  <article-title>Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus</article-title>. 
  <source>J. Virol.</source>
  <volume>69</volume>(
  <issue>5</issue>), 
  <fpage>3206</fpage>â€“
  <lpage>3210</lpage> (
  <year>1995</year>).
  <pub-id pub-id-type="pmid">7707552</pub-id>
 </mixed-citation>
</ref>
